KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Humana (HUM) EBIT Margin (2016 - 2025)

Humana (HUM) has disclosed EBIT Margin for 16 consecutive years, with 1.32% as the latest value for Q4 2025.

  • On a quarterly basis, EBIT Margin changed N/A to 1.32% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.05%, a N/A change, with the full-year FY2025 number at 2.09%, up 39027.0% from a year prior.
  • EBIT Margin was 1.32% for Q4 2025 at Humana, up from 571.97% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 118.7% in Q3 2023 to a low of 571.97% in Q2 2025.
  • A 4-year average of 22.83% and a median of 5.66% in 2022 define the central range for EBIT Margin.
  • Peak YoY movement for EBIT Margin: crashed -24738bps in 2021, then surged 11356bps in 2023.
  • Humana's EBIT Margin stood at 0.34% in 2021, then tumbled by -159bps to 0.2% in 2022, then surged by 59126bps to 118.7% in 2023, then tumbled by -101bps to 1.32% in 2025.
  • Per Business Quant, the three most recent readings for HUM's EBIT Margin are 1.32% (Q4 2025), 571.97% (Q2 2025), and 6.27% (Q1 2025).